Mutations in superoxide dismutase 1 (SOD1) are found in approximately 20% of patients with familial amyotrophic lateral sclerosis. The propensity of mutant SOD1 to form aggregates in pathologically affected cells (i.e. motor neurons) has implicated these poorly soluble protein aggregates and/or their misfolded soluble precursors as being instrumental to the disease process. We investigated the relative solubility and toxicity of four different mutant SOD1 proteins in a cell-based model system and demonstrate that the mutant, misfolded SOD1 proteins that are the most soluble are also the most toxic. This toxicity was ameliorated by upregulating heat-shock protein chaperones in order to refold the soluble, misfolded protein, regardless of the presence of poorly soluble SOD1. We further demonstrate that increasing the solubility of a SOD1 mutant protein that is both poorly soluble and non-toxic, as compared to other mutant proteins, resulted in remarkably increased toxicity of the mutant SOD1. Again, this increased toxicity was attenuated by upregulating heat-shock protein chaperones in order to refold the soluble, misfolded proteins. These findings implicate easily soluble, misfolded SOD1 as being toxic to the cell and support the hypothesis that reducing solubility of mutant SOD1 proteins through aggregation may occur as a self-protective response in the cell.
Introduction
Amyotrophic lateral sclerosis (ALS) is an invariably fatal neurodegenerative disorder that primarily targets the motor system, affecting 1-2 people per 100,000 persons worldwide (Logroscino et al., 2007; Worms, 2001) . Approximately 10% of ALS cases are familial, and about 20% of these families harbor a disease causing mutation in the gene superoxide dismutase 1 (SOD1) (Chio et al., 2008; Gaudette et al., 2000; Rosen et al., 1993) . SOD1 is a ubiquitously expressed, 153 amino acid homodimeric protein whose primary function is detoxification of oxygen free radicals in the cell (Fridovich, 1986; Mccord and Fridovic, 1969) . However, mutant SOD1 proteins do not lose their enzymatic function and their role in ALS pathogenesis is related to an, as of yet, undefined toxic gain of function (Borchelt et al., 1994; Gurney et al., 1994; Wong et al., 1995) . Rodents expressing the mutated human SOD1 transgene reliably mimic disease pathogenesis and are commonly used to model ALS (Gurney et al., 1994; Wong et al., 1995) .
Protein aggregation is a pathological hallmark of many neurodegenerative diseases, including ALS (Ross and Poirier, 2004) . SOD1 is a primary component of protein aggregates found in patients carrying SOD1 mutations and in mutant SOD1 rodent disease models. Antibodies specific for misfolded forms of SOD1 have shown that granular SOD1 inclusions can be found in autopsy tissues from sporadic ALS patients, providing a possible mechanistic link between the sporadic and familial forms of disease (Bosco et al., 2010; Forsberg et al., 2010 Forsberg et al., , 2011 . The role of these aggregates in disease pathogenesis is unclear. Past research has focused heavily on aggregates being cytotoxic, but recent evidence implies that the aggregates may actually be innocuous, or even cytoprotective (Bodner et al., 2006; Finkbeiner et al., 2004; Walsh et al., 2002) . Mutant SOD1 is known to misfold into a disordered tertiary structure, and it may be this soluble, misfolded form of SOD1 that is cytotoxic (Banci et al., 2007; Durazo et al., 2009; Shaw et al., 2006) . In this paradigm, aggregates form as a compensatory response to sequester away toxic improperly folded soluble protein. Supporting this theory are data from transgenic mutant SOD1 rodents demonstrating that soluble, misfolded SOD1 is enriched in pathologically affected tissues prior to disease onset, whereas SOD1 aggregates increase most markedly after symptom onset (Johnston et al., 2000 (Johnston et al., , 2004 Wang et al., 2002; Zetterstrom et al., 2007) . The relative dearth of SOD1 aggregates pre-symptomatically implies that SOD1 aggregates may not be the primary driver of disease initiation. In contrast, because improperly folded soluble SOD1 is present prior to symptom onset and accumulates in pathologically affected tissue leading up to symptom Neurobiology of Disease 49 (2013) 
